谷歌浏览器插件
订阅小程序
在清言上使用

Phase 1 Evaluation of Triple Therapy with Boserolimab (Anti-Cd27 Agonist), Pembrolizumab, and Chemotherapy in Patients with Triple-Negative Breast Cancer (TNBC) with PD-L1 Combined Positive Score (CPS) <10: Safety, Antitumor Activity, and Association Between Biomarkers and Response

CANCER RESEARCH(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要